The importance of determining concentrations of drugs in the blood, as well as the numerous modifying gists (2) (3) (4) (5) (6) .
However, this type of guide has rarely provided sufficient information for one to judge the validity of a comparison between the data in the guide and the results that are to be interpreted. For example, chloral hydrate may be listed as yielding a therapeutic blood concentration of 1.0 mg% (4). We are not told the amount administered, or whether the drug was given orally or intramuscularly.
Was chloral hydrate itself measured, or does the figure include or represent an active metabolite? Is this concentration applicable to both single administration and chronic usage? How many persons were studied to obtain this result, and were they children or adults? Would you expect this concentration 2 h or 24 h after administration of the drug?
The answers to these questions, necessary as a basis for the interpretation of a patient's drug concentration, are to be found for many drugs in the scientific literature. In this paper, which represents a comprehensive literature search, we have collected the available data on some drug concentrations in man, specifically those drugs likely to be encountered in cases of overdose and those studies that best provide a basis for interpretation of actual clinical situations.
Drugs Studied
The original drug list that we used as the basis for and miscellaneous drugs that do not act on the central nervous system were excluded from the list, but several common "street drugs"
were added. Both therapeutic and toxic concentrations were found for 48 drugs; such data are entered into Tables 1 and 2 , respectively. Incomplete data were found for another 62 drugs. Situations that involve multiple drug usage (including ethanol) are not included in this compilation. For the sake of simplicity, we also excluded data on sustained-release drugs and data obtained on overdose situations involving traumatic injury.
If several similar studies were encountered on a particular drug, that study was selected which provided the most information relevant to the factors presented here. -;
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We have attempted to restrict the data tabulated it was based on the combined experience of these au- 
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apeutic" or "toxic" in Tables 1 and 2 In several instances, such as the case of a woman who ingested 1 g of amphetamine daily (Table 1) , it was a problem to decide into which table the entry should go. In general, cases involving the administration of abuse-type drugs that did not result in serious
-.
C C
toxicity have been treated as therapeutic situations. The route of administration of a compound is of obvious importance in determining the peak blood concentration to be attained and the time at which it was attained.
In general, intravenous or inhalation administrations result in initially high but shortlived concentrations in blood, while oral or intramuscular administrations of a similar dosage produce lower, more prolonged drug concentrations. The route of administration has been indicated in very nearly all of the studies included in this paper. Data comparing various routes have been included whenever available.
How often a drug is administered to a patient can be extremely important in determining the resulting blood concentration.
Diphenylhydantoin, for example, given at a dosage of 600 mg to volunteers on a single occasion, produced sedation at relatively low blood concentrations, while only half that amount of drug given on a chronic daily basis to epileptics resulted in higher blood concentrations with few outward signs of intoxication (Table 1) . A further effect of frequency of administration is on the extent and rate of drug metabolism.
A number of active drug metabolites, such as phenobarbital in the case of mephobarbital or primidone administration, will not make a measurable appearance in the blood until after several consecutive daily administrations of the parent drug. Thus, the parent drug/metabolite concentration ratio is one means of differentiating chronic administration from acute overdosage for certain drugs.
Subjects
The primary pharmacological determinant of concentrations of drugs in blood after a particular dosage to various subjects is body weight. The rule of thumb that states that dosage should be proportionate to body weight is valid for most drugs. Thus, when a 19-kg child exhibits a plasma acetazolamide concentration of 60 tg/ml after a 1550-mg oral dose (Table  1) , it may be reasonably expected that a 60-kg adult will achieve about one-third that plasma value with the same amount of drug. Body weight has been recorded in the Tables as an average of the subjects under study, although occasionally we could only indicate a weight range, or whether the subjects were children or adults.
Age and sex, independent of body weight, are pharmacological factors that are less likely to significantly influence circulating drug concentrations.
Genetic factors affecting the rate of drug metabolism or the extent of plasma protein binding are probably more important.
Although impossible to predict when dealing with a single overdose victim, genetic control of blood concentrations of drugs can certainly be taken into account by use of large numbers of subjects in clinical studies to yield a range of expected concentrations.
We have indicated concentration ranges for subject groups whenever possible.
We have not as yet discussed individual response to particular drug concentrations.
Although the attainment of these concentrations is the result of many underlying factors, it is generally understood that normal individuals do not vary significantly with respect to the pharmacological effects produced by certain well-defined blood concentrations of most drugs (1) . On the other hand, abnormalities, such as pathological damage or tolerance because of chronic usage, should not be overlooked in interpreting the response to a drug concentration.
Choice of Specimens
In studies cited in this review, blood, plasma, or serum were used for the analytical determination; the specimen is indicated for each drug by a B, P, or S after the drug concentration.
Most forensic laboratories are accustomed to performing their determinations on whole blood, while clinical facilities may be prepared to accept any of the three choices.
Studies relating concentrations of drugs in whole blood to simultaneous plasma or serum determinations are conspicuous by their absence. It is theoretically possible to have, on one extreme, a drug restricted entirely to the plasma, yielding a whole blood/plasma ratio of 0.5; and on the other extreme, a drug confined exclusively to the erythrocytes, resulting in a whole blood/plasma ratio of infinity. For most drugs, this ratio will lie within the range of 0.5 to 1. However, unless this ratio has been established for the drug and the concentration in question, a direct conversion between blood and plasma or serum concentrations should not be attempted.
Time
We have attempted, wherever possible, to give an indication of the relative persistence of drugs in the body by reporting blood concentrations at various time intervals after administration.
Thus, it is evident that ethosuximide will be present in significant amounts two days after a single administration, while a drug such as p-aminosalicylic acid will almost wholly dissipate in 12 h (Table 1) . This information may be somewhat useful in treating victims of drug overdosage.
There are complicating factors when dealing with large amounts of drugs, which may hamper the estimation of a drug-dissipation rate, or halflife. These factors can include depression of respiration and circulation by the drug itself, resulting in impaired drug metabolism and excretion; depression of gastrointestinal motility, causing drug absorption to continue slowly over a long period of time; or simply the saturation of drug disposition mechanisms.
Caveat
This paper is intended to provide general, but pharmacologically sound, guidelines for interpretation of human blood concentrations of certain drugs. While it may be tempting for the scientist with limited experience in toxicology to use these data as an absolute and ultimate guide in interpretation, this should be avoided. We have pointed out many of the factors which must be considered when attempting to reach a decision regarding the effect on a patient of a certain drug concentration.
The comments of Winek (4) and Sunshine (6) are also very relevant to this paper and should be considered by all persons involved in establishing the significance of drug concentrations, regardless of experience.
